Wells Fargo
CDIO icon

Wells Fargo’s Cardio Diagnostics CDIO Stock Holding History

Wells Fargo’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Buy
+2
New +$4 ﹤0.01% 7164
2024
Q2 		– Sell
-4
Closed -$190 – 6971
2024
Q1 		$190 Hold
4
– – ﹤0.01% 6506
2023
Q4 		$291 Buy
4
+2
+100% +$69 ﹤0.01% 6512
2023
Q3 		$16 Buy
2
+1
+100% +$24 ﹤0.01% 7276
2023
Q2 		$52 Hold
1
– – ﹤0.01% 7042
2023
Q1 		$160 Hold
1
– – ﹤0.01% 6833
2022
Q4 		$43 Buy
+1
New +$108 ﹤0.01% 7062

Other funds holding CDIO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo's CDIO Position: Q2 2026 in Review

Wells Fargo opened a new position in Cardio Diagnostics (CDIO) in Q2 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #7164 among its holdings. This is a return to the name: Wells Fargo previously reported a position in CDIO as recently as Q1 2024.

Wells Fargo first reported a position in CDIO in Q4 2022 and has held it in 7 quarters since. The position peaked at $291 in Q4 2023. 17 funds tracked by Wall St. Rank hold CDIO as of Q2 2026.

  • Wells Fargo held 2 shares of Cardio Diagnostics worth $4 as of Q2 2026.
  • Cardio Diagnostics was a new Wells Fargo position in Q2 2026.
  • Cardio Diagnostics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #7164 holding.
  • Wells Fargo first reported a position in Cardio Diagnostics in Q4 2022 and has held it in 7 quarters since.
  • Wells Fargo's Cardio Diagnostics position peaked at $291 in Q4 2023.
  • 17 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.